Reprinting FDAMA Approach: Waxman Urges FDA Review Of Off-Label Articles

Rep. Henry Waxman, D-Calif., is pushing FDA to require companies to submit reprints of journal articles on off-label use before providing them to practitioners, should the agency go forward with guidance permitting off-label promotion